Mismatch repair (MMR) deficiency occurs in 10–20% of colorectal cancer (CRC) cases, leading to microsatellite instability (MSI). Although MSI/MMR testing is critical for CRC management, high costs and ...
根治切除可能な大腸癌に対する術前MMR/MSI検査の実施率は普及啓発活動後で30％未満にとどまり、検査の意義に対するリテラシーの向上や、術前MMR/MSI検査を実施するフローの構築が重要な課題であることが示された。
Although the majority of patients are diagnosed with early-stage disease, outcomes remain poor for those with primary advanced or recurrent endometrial cancer, with reported 5-year survival rates as ...
The assessment compared tumour testing strategies involving microsatellite instability (MSI) testing, immunohistochemistry (IHC) testing (both with and without further testing to exclude sporadic ...
Testing colorectal tumours using either microsatellite instability (MSI) or immunohistochemistry (IHC) testing for mismatch repair (MMR) proteins can identify people in whom the cancer may have ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する